Velocity Clinical Research Luebeck GmbH
- Address
- lock Available on a paid plan
Velocity Clinical Research Luebeck GmbH - Respiratory Medicine Research Center
Velocity Clinical Research Luebeck GmbH is a specialized research center dedicated to advancing the treatment of respiratory diseases through innovative clinical trials. The center demonstrates particular expertise in conducting Phase 2 and Phase 3 studies evaluating novel therapeutic interventions for chronic respiratory conditions, with a focus on both common and complex pulmonary disorders.
- Chronic Obstructive Pulmonary Disease (COPD) including moderate-to-severe disease and exacerbation prevention studies
- Refractory and Unexplained Chronic Cough using novel inhalation therapies and cough frequency monitoring
- Moderate-to-Severe Uncontrolled Asthma with focus on biologics and targeted therapeutic approaches
- Bronchiectasis long-term safety and efficacy evaluations
The center's research portfolio encompasses a diverse range of respiratory therapeutic areas, from evaluating biologic agents and inhaled medications to conducting comprehensive long-term safety assessments. Their expertise in managing complex respiratory trials positions them as a key contributor to the development of next-generation treatments for patients with challenging-to-treat pulmonary conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 9 therapeutic areas and 15 of 54 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 49 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 18 by active trials.
- 1AstraZeneca AB6active
lock +17 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB13trials
lock +11 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Velocity Clinical Research Luebeck GmbH
lock Showing 1 of 60 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A 2-year Open-label Extension Study to Assess the Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis | Almirall S.A. | Phase III | Not Recruiting | May 2023 | Apr 2026 |
IMP list
lock Showing 1 of 54 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Glycopyrronium Bromide | 6 | Unknown | 2023-10-19 | 2026-04-13 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.